Cargando…

Social preferences for health states associated with acute myeloid leukemia for patients undergoing treatment in the United Kingdom

BACKGROUND: Health state (HS) utility values for patients with acute myeloid leukemia (AML), a hematological malignancy, are not available in the United Kingdom (UK). This study aims to develop clinically sound HSs for previously untreated patients with AML and to assign utility values based on pref...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castejón, Nacho, Cappelleri, Joseph C., Cuervo, Jesús, Lang, Kathryn, Mehta, Priyanka, Mokgokong, Ruth, Mamolo, Carla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907377/ https://www.ncbi.nlm.nih.gov/pubmed/29669568 http://dx.doi.org/10.1186/s12955-018-0897-8

Ejemplares similares

Budget Impact Analysis of Gemtuzumab Ozogamicin for the Treatment of CD33-Positive Acute Myeloid Leukemia
por: Mamolo, Carla, et al.
Publicado: (2020)

Cost-Effectiveness of Bosutinib for the Treatment of Adult Patients with Chronic Phase Chronic Myeloid Leukemia in the Second-Line Setting
por: Muresan, B., et al.
Publicado: (2021)

Relationship between molecular response and quality of life with bosutinib or imatinib for chronic myeloid leukemia
por: Brümmendorf, Tim H., et al.
Publicado: (2020)

Psychometric properties of the incontinence utility index among patients with idiopathic overactive bladder: data from two multicenter, double-blind, randomized, Phase 3, placebo-controlled clinical trials
por: Castejón, Nacho, et al.
Publicado: (2015)

Development of the Incontinence Utility Index: estimating population-based utilities associated with urinary problems from the Incontinence Quality of Life Questionnaire and Neurogenic Module
por: Cuervo, Jesús, et al.
Publicado: (2014)

Cost-effectiveness analysis for midostaurin versus standard of care in acute myeloid leukemia in the United Kingdom
por: Tremblay, Gabriel, et al.
Publicado: (2018)

Population preference values for health states in relapsed or refractory B-precursor acute lymphoblastic leukemia in the United Kingdom
por: Aristides, Mike, et al.
Publicado: (2015)

A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies
por: Callis Duffin, Kristina, et al.
Publicado: (2019)

Cost Effectiveness of Gemtuzumab Ozogamicin in the First-Line Treatment of Acute Myeloid Leukaemia in the UK
por: Russell-Smith, T. Alexander, et al.
Publicado: (2021)

Successful Treatment of Acute Myeloid Leukemia with CPX-351 in 2 Patients in the United Kingdom during the COVID-19 Pandemic
por: Munisamy, Sreetharan, et al.
Publicado: (2021)

Determination of fitness and therapeutic options in older patients with acute myeloid leukemia
por: Cortes, Jorge E., et al.
Publicado: (2021)

Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes
por: Panés, Julián, et al.
Publicado: (2015)

Patients’ preferences for bone metastases treatments in France, Germany and the United Kingdom
por: Hechmati, Guy, et al.
Publicado: (2014)

Physicians’ preferences for bone metastases treatments in France, Germany and the United Kingdom
por: Qian, Yi, et al.
Publicado: (2018)

Societal preference values for advanced melanoma health states in the United Kingdom and Australia
por: Beusterien, K M, et al.
Publicado: (2009)

A retrospective observational research study to describe the real‐world use of bosutinib in patients with chronic myeloid leukemia in the United Kingdom and the Netherlands
por: Claudiani, Simone, et al.
Publicado: (2022)

Current treatment preferences in acute myeloid leukemia: a survey in Brazil
por: Portugal, Rodrigo Doyle, et al.
Publicado: (2020)

Is allogeneic transplantation the preferred therapy for older patients with acute myeloid leukemia?
por: Ganser, Arnold
Publicado: (2022)

Response rates and minimal residual disease outcomes as potential surrogates for progression-free survival in newly diagnosed multiple myeloma
por: Daniele, Patrick, et al.
Publicado: (2022)

A General Public Study on Preferences and Welfare Impacts of Antimicrobial Resistance in the United Kingdom
por: Dorgali, Maria Veronica, et al.
Publicado: (2021)

Karyotypic findings in chronic myeloid leukemia cases undergoing treatment
por: Kaur, Anupam, et al.
Publicado: (2012)

Patient and physician preferences for ulcerative colitis treatments in the United States
por: Boeri, Marco, et al.
Publicado: (2019)

Disability discrimination and well-being in the United Kingdom: a prospective cohort study
por: Hackett, Ruth A., et al.
Publicado: (2020)

Models of care for chronic myeloid leukemia patients during the COVID‐19 pandemic in the United Kingdom: Changes in patient attitudes to remote consultations and future implications
por: Duncan, Nicholas, et al.
Publicado: (2021)

Mortality in vegetarians and comparable nonvegetarians in the United Kingdom(1)(2)(3)
por: Appleby, Paul N, et al.
Publicado: (2016)

PREFERENCES OF PATIENTS WITH MULTIPLE SCLEROSIS FOR ATTRIBUTES OF INJECTABLE MULTIPLE SCLEROSIS TREATMENTS IN THE UNITED KINGDOM AND FRANCE
por: Poulos, Christine, et al.
Publicado: (2018)

Long‐term patient‐reported outcomes from an open‐label safety and efficacy study of bosutinib in Philadelphia chromosome–positive chronic myeloid leukemia patients resistant or intolerant to prior therapy
por: Kantarjian, Hagop M., et al.
Publicado: (2017)

United Kingdom Memorandum
por: European Council for Nuclear Research
Publicado: (1952)

United Kingdom art
por: Anderson, Hephzibah
Publicado: (2004)

Women’s birth place preferences in the United Kingdom: a systematic review and narrative synthesis of the quantitative literature
por: Hollowell, Jennifer, et al.
Publicado: (2016)

Patient and physician preferences for first‐line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom
por: Bröckelmann, Paul J., et al.
Publicado: (2018)

Could Miscanthus replace maize as the preferred substrate for anaerobic digestion in the United Kingdom? Future breeding strategies
por: Purdy, Sarah J., et al.
Publicado: (2017)

Parental Knowledge of Appendicitis and Preference for Operative or Non-Operative Treatment at a United Kingdom Children’s Hospital
por: Monks, Kitty, et al.
Publicado: (2022)

Demethylator phenotypes in acute myeloid leukemia
por: Kelly, Andrew D., et al.
Publicado: (2018)

Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis
por: De Rosa, Francesco Giuseppe, et al.
Publicado: (2013)

Preference and Values of Stroke Interventions, Kingdom of Saudi Arabia
por: Alamri, Reem, et al.
Publicado: (2019)

Under-Treatment of Patients with Moderate to Severe Psoriasis in the United States: Analysis of Medication Usage with Health Plan Data
por: Armstrong, April W., et al.
Publicado: (2016)

Flea and tick treatment satisfaction, preference, and adherence of dog owners in the United States, United Kingdom, and Australia who treated their dog with fluralaner
por: Lavan, Robert, et al.
Publicado: (2020)

Preferences for Medical Consultations from Online Providers: Evidence from a Discrete Choice Experiment in the United Kingdom
por: Buchanan, James, et al.
Publicado: (2021)

Cutaneous Legionella longbeachae Infection in Immunosuppressed Woman, United Kingdom
por: Grimstead, Daniel, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hbu5h8m8ndr25frql2hc4ibk0t